Home ›› Back


Indian Journal of Cancer

Table of Contents RSS Feed
2017| December  | Volume 54 | Issue 5  

Please wait, loading Google Map...

REVIEW ARTICLES  
Oncogenic drivers in nonsmall cell lung cancer and resistance to epidermal growth factor receptor tyrosine kinase inhibitors p. 1
A Pathak, S Rajappa, A Gore
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor mutation testing: From conventional to real-time diagnosis of lung cancer p. 9
T Raja, NK Warrier
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor T790M mutation: A major culprit in the progression of epidermal growth factor receptor-driven non-small cell lung cancer and the role of repeat biopsy p. 15
S Aggarwal, S Patil, N Rohtagi
[ABSTRACT]  [HTML Full text]  [PDF]
Liquid biopsy: A potential and promising diagnostic tool for advanced stage non-small cell lung cancer patients p. 25
DC Doval, R Deshpande, B Dhabhar, KG Babu, K Prabhash, R Chopra, PV Sripada, C Deshmukh, M Suryavanshi
[ABSTRACT]  [HTML Full text]  [PDF]
Advanced therapeutic options and importance of rebiopsy in epidermal growth factor receptor-tyrosine kinase inhibitor-progressed nonsmall cell lung carcinoma patients: An expert opinion p. 31
Suresh H Advani, Hemant Malhotra, Raju Titus Chacko, Maheboob Basade, Pavithran Keechilat, PN Mahapatra, Chanchal Goswami, TP Sahoo, Chirag Shah
[ABSTRACT]  [HTML Full text]  [PDF]
Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients p. 37
U Batra, N Lokeshwar, S Gupta, P Shirsath
[ABSTRACT]  [HTML Full text]  [PDF]
Epidermal growth factor receptor T790M testing in progressed lung cancer: A review of sensitive methods for analysis of tissue and liquid biopsy samples p. 45
A Chougule, S Basak
[ABSTRACT]  [HTML Full text]  [PDF]
A review on adverse event profiles of epidermal growth factor receptor-tyrosine kinase inhibitors in nonsmall cell lung cancer patients p. 55
B Biswas, N Ghadyalpatil, MV Krishna, J Deshmukh
[ABSTRACT]  [HTML Full text]  [PDF]
CASE REPORT Top
Importance of repeat tissue biopsy and tissue-based epidermal growth factor receptor T790M testing in progressed nonsmall cell lung carcinoma patients upon negative plasma genotyping for selection of third-generation tyrosine kinase inhibitor therapy: A case study p. 65
R Mistry, A Patil
[ABSTRACT]  [HTML Full text]  [PDF]